MedTech Dive

Dexcom recalls G6 CGM app over software problem

A software defect could cause the app to terminate, resulting in missed alerts or alarms. Dexcom required users to update the app.
Medical Device and Diagnostic Industry (MD+DI)

Dexcom Faces G6 Recall

Dexcom has issued a Class I recall for its G6 Android app due to crashes that could cause users to miss critical glucose ...
Fierce Biotech

Dexcom hit by FDA Class I recall for its continuous glucose monitoring system app

Dexcom has been hit by a major safety issue for an Android version of its G6 continuous monitoring system app, leading the FDA to issue its most serious recall notice. | Dexcom has been hit by a major ...

DexCom Stock Just Fell to a 5-Year Low. Is It a No-Brainer Buy at This Price?

DexCom's growth rate has been improving, but that hasn't been enough of a reason for investors to buy up the stock.
The Malaysian Reserve

DXCM Stockholders With Large Losses Should Contact Robbins LLP for Information About Leading the Dexcom, Inc. Securities Fraud Class Action

The Case: Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Dexcom, Inc. securities during the class period because the Company ...

How Recent Developments Are Reshaping the DexCom Investment Story

DexCom's stock narrative has shifted as analysts lower their fair value estimate from $98.40 to $84.96, marking a significant downward revision in the price target. This adjustment is primarily driven ...
The Malaysian Reserve

Shareholders who lost money in shares of DexCom, Inc. (NASDAQ: DXCM) Should Contact Wolf Haldenstein Immediately

Lead Plaintiff Deadline is December 26, 2025 NEW YORK, Nov. 11, 2025 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP reminds  investors that ...
Barron's

DexCom Inc.

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include ...

1 Spectacular Growth Stock Down 20% to Buy Right Now, According to Wall Street

Since last year, DexCom (NASDAQ: DXCM) has faced a series of issues that have sunk its stock price. The medical device specialist's shares are down 20% over the trailing-12-month ...

Carrot Partners with URA and Dexcom to Deliver Deeper Insights and Experiences for Members on Fertility, Family-Building, and Hormonal Health Journeys

Carrot today announced a partnership with URA, the world's leading smart ring, and Dexcom, the global leader in glucose biosensing, to empower members with actionable, personalized insights that ...
newscase

DexCom Shares Face Critical Regulatory Challenges

DexCom, a leading manufacturer of continuous glucose monitoring systems, is confronting one of the most significant ...
pharmaphorum

Glooko and Dexcom expand diabetes deal

The deal concerns the connectivity between Glooko's self-titled mobile app and Dexcom's continuous glucose monitoring (CGM) devices. Currently, Dexcom device users upload CGM data to the Glooko app ...